Clinical trials
Osteoporosis clinical trials
Below are recruiting osteoporosis clinical trials, each written for real people, not researchers. We’re tracking 124 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07486076Enrolling by invitation
Osteoporosis education for women at risk
This trial tests whether an education program can improve women's understanding and beliefs about osteoporosis. If you are a woman over 45 without osteoporosis but with risk factors, you may be able to join and learn ways to protect your bone health.
BartınAges 45–80 - NCT06431867Recruiting
Managing osteoporosis in older women
This study tests a new way for primary care doctors to help older women manage osteoporosis. It aims to find better strategies for treatment and follow-up in the community.
Bradford, West YorkshireAges 70 years+ - NCT07406685RecruitingPhase 4
Comparing two bone medicines after stopping denosumab
This study compares two medicines (ibandronate and zoledronic acid) to see which one works better at keeping bones strong after stopping denosumab (Prolia). It's for postmenopausal women with mild to moderate bone thinning.
TaipeiAges 50–85 - NCT07367776Recruiting
Online education program for osteoporosis (RCT-PATOS)
This trial tests a digital education program for people with osteoporosis or osteopenia. It aims to help you learn more about your bone health and how to manage it, all from home using the 1177.se platform.
GävleAges 50 years+ - NCT06915935Recruiting
Osteoporosis study in older adults in Shandong
This trial is a study to understand how common osteoporosis is in people aged 65 and older living in Shandong province. By joining, you help researchers learn more about bone health in older adults.
Jinan, ShandongAges 65 years+ - NCT06938152RecruitingPhase 4
Comparing two bone-strengthening drug schedules for osteoporosis
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
TaipeiAges 50–90 - NCT06551155Recruiting
Blood test to screen bone health and fracture risk
This study uses a simple blood test to look for early signs of bone loss and fracture risk. It's for people 40 and older who are either healthy, have early bone thinning, or have known osteoporosis.
BolognaAges 40 years+ - NCT07876882Recruiting
Comparing two bone scans for osteoporosis diagnosis
This study compares a newer, no-radiation bone scan (REMS) with the standard DXA scan to see if it's just as good at diagnosing osteoporosis and predicting fractures. If you're already getting a DXA scan, you might be able to participate and help improve bone health testing.
Easton, MarylandAges 30–90 - NCT03755193RecruitingPhase 2
Testing another osteoporosis medicine after 2 years of denosumab
This study looks at how well and how safely another osteoporosis medicine works for people who have already taken denosumab for 2 years. It may help find the best next step to strengthen bones and lower fracture risk after denosumab.
Matsumoto, NaganoAges 20–120 - NCT02958020Recruiting
Osteoporosis study for adults age 45 to 79
This study collects health information to learn more about osteoporosis and who is most at risk. It may help researchers better understand prevention and early detection, based on your survey responses and basic health details.
Shenzhen, GuangdongAges 45–79 - NCT05132348Recruiting
Studying immune markers in people with osteoporosis
This study looks at immune system “fingerprints” (immunophenotyping) in adults who have been diagnosed with osteoporosis. It may help researchers understand what drives osteoporosis and could guide better future treatments.
Bonn, Northrhine WestfaliaAges 18 years+ - NCT05228262Recruiting
Testing blood-vessel function and muscle strength in osteoporosis
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
Clermont-FerrandAges 50 years+ - NCT05904353Recruiting
Care coordination program after hip fracture and osteoporosis
This trial aims to improve how primary care and hospital care work together to treat osteoporosis after a hip fracture. It may help by making follow-up treatment plans and communication clearer after your hip injury.
Lørenskog, AkershusAges 75 years+ - NCT06379243Recruiting
Predicting future spinal fractures after osteoporosis treatment
This study is testing a new way to predict if your spine might break again after you have treatment for a fracture caused by osteoporosis. If you have a recent spinal fracture from weak bones and are getting a cement injection (PVP or PKP), researchers want to check your information to see how well their risk model works for people like you.
Guangzhou, GuangdongAges 50–90 - NCT07677072Recruiting
Studying a blood protein to detect hidden bone fragility
This study looks at a protein called lumican in the blood to see if it can help find women who have fragile bones even if their bone density test looks normal. It's for postmenopausal women who are already getting a bone density scan as part of their routine care.
Küçükçekmece, IstanbulAges 45 years+ - NCT07645794Enrolling by invitation
MRI Scans to Detect Bone and Muscle Loss in Kidney Disease
This study tests a new MRI imaging method to detect bone loss (osteoporosis) and muscle loss (sarcopenia) in people with chronic kidney disease. The scan may help doctors catch these problems earlier and manage kidney disease better.
Beijing, Beijing MunicipalityAges 18–80 - NCT07620834Recruiting
AI-Guided Bone Density Screening for High-Risk Adults
This study tests whether artificial intelligence can help identify people at risk for weak bones (osteoporosis) using chest X-rays. If you qualify, you'll be randomly assigned to either standard screening or AI-enhanced screening to see which approach works better.
ChanghuaAges 40–80 - NCT07621679Recruiting
Walking Program to Prevent Falls and Fractures in Older Adults
This study tests whether a specialized walking and balance program helps people aged 70+ with weak bones reduce their risk of falls and fractures. The program is designed to improve strength, balance, and confidence in daily movement.
Montreal, QuebecAges 70 years+ - NCT07616401Recruiting
Bone-Strengthening Drugs and Biomarkers in Postmenopausal Osteoporosis
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
Miano, LombardyAges 50 years+ - NCT06655701Recruiting
Bladder leaks and muscle loss in postmenopausal women with bone thinning
This study looks at whether women with osteoporosis (thin bones) after menopause also have bladder leaks and loss of muscle mass. It may help understand links between these conditions.
IstanbulAges 50–75 - NCT05202678Recruiting
Check a new therapy for osteoporosis-related hip bone loss
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
Sint-Niklaas, AntwerpenAges Any age - NCT07421713Recruiting
AI and chest x-rays to screen for osteoporosis
This trial tests if an AI software can use a chest x-ray to screen for osteoporosis, compared to the standard DXA bone density scan. It may offer a faster, simpler way to check bone health in people 50 and older.
RotterdamAges 50 years+ - NCT07419451Recruiting
Bone health and health knowledge study for older adults
This study looks at how much older adults know about osteoporosis and their overall health understanding. It aims to help improve education and awareness about bone health in aging.
Balıkesir, BandırmaAges 65 years+ - NCT02719314Recruiting
Study bone loss from steroid use in people with inflammatory disease
This study looks at how steroid medicines (called glucocorticoids) affect bone strength in people with long-term inflammatory rheumatic conditions or psoriasis. It may help improve how doctors check and manage osteoporosis risk and bone metabolism over time.
BerlinAges 18 years+
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Osteoporosis trials by city
Studies with a site in or near these metro areas.
Osteoporosis trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for osteoporosis?
- Yes. Clin2 currently lists 124 recruiting osteoporosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a osteoporosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a osteoporosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.